New hope for tough lung cancer: major trial tests experimental drug

This study is testing whether a new experimental drug called ABBV-706 works better than current standard treatments for aggressive small cell lung cancer that has returned or stopped responding to prior therapy. About 531 adults worldwide will receive either the new drug or one of three standard treatments through an IV or pills. Researchers will measure how well the cancer shrinks, how long patients live, and how the treatment affects their quality of life and daily functioning.